Profound Medical (PROF) Non-Current Debt (2018 - 2026)
Profound Medical's (PROF) quarterly Non-Current Debt came in at $4.5 million in Q1 2026, little changed year-on-year from $4.5 million in Q1 2025, and little changed quarter-over-quarter from $4.5 million in Q4 2025.
Profound Medical (PROF) Non-Current Debt (2018 - 2026) Analysis & Trends
Profound Medical's Non-Current Debt history runs 7 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- On a quarterly basis, Non-Current Debt changed 0.38% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 0.38% change from a year earlier, with the FY2025 full-year figure at $4.5 million, down 3.48% from the prior year.
- Non-Current Debt held at $4.5 million in Q1 2026 per PROF's latest filing, from $4.5 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $7.2 million in Q4 2022 and bottomed at $4.5 million in Q2 2025.
- The 5-year median for Non-Current Debt is $4.5 million (2025), against an average of $5.2 million.
- Across the five-year window, Non-Current Debt plunged 34.39% in 2024 and rose 0.38% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $7.2 million in 2022, then retreated by 0.98% to $7.1 million in 2023, then tumbled by 34.39% to $4.7 million in 2024, then retreated by 3.48% to $4.5 million in 2025, then climbed by 0.09% to $4.5 million in 2026.
- Per Business Quant, the three latest PROF Non-Current Debt figures stand at $4.5 million (Q1 2026), $4.5 million (Q4 2025), and $4.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Profound Medical | 273.14 Mn | 222.85 Mn | 3.83 Mn | 4.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.50 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | 4.49 Mn |
| Dec 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Dec 31, 2022 | 7.17 Mn |
| Dec 31, 2019 | 5.09 Mn |
| Jan 1, 2019 | 7.78 Mn |
| Dec 31, 2018 | 8.04 Mn |